menu
    • menu

    Company profile for ENA Respiratory

    NEW Drugs in Dev: 1
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    ENA Respiratory is a biotechnology company aiming to transform the treatment and prevention of respiratory infections in at-risk populations. Ena Respiratory is developing novel, synthetic innate immunomodulators for the prevention of respiratory viral and bacterial infections. The company is based in Melbourne, Australia and it has secured a Series A investment from the Brandon Capital managed Medical Research Commercialisat...
    ENA Respiratory is a biotechnology company aiming to transform the treatment and prevention of respiratory infections in at-risk populations. Ena Respiratory is developing novel, synthetic innate immunomodulators for the prevention of respiratory viral and bacterial infections. The company is based in Melbourne, Australia and it has secured a Series A investment from the Brandon Capital managed Medical Research Commercialisation Fund (MRCF) and Uniseed.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ENA RespiratoryAustralia Flag
    Country
    Country
    Australia
    Address
    Address
    31 Queen Street, Melbourne 3000
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://enarespiratory.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Natural Product Expo West

    Natural Product Expo West

    Not Confirmed

    envelop Contact Supplier

    Natural Product Expo West

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    ENA Doses First Patients in INNA-051 Nasal Phase II Trial
    ENA Doses First Patients in INNA-051 Nasal Phase II Trial

    29 Jan 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-01-29/ena-respiratory-announces-dosing-of-first-participants-in-phase-ii-study-of-inna-051-nasal-spray-designed-to-protect-against-symptomatic-viral-respira-1

    PHARMIWEB
    29 Jan 2026
    Share Share
    ENA Respiratory Secures $22.4M For INNA-051 Nasal Spray Phase II
    ENA Respiratory Secures $22.4M For INNA-051 Nasal Spray Phase II

    22 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/22/3170783/0/en/ENA-Respiratory-Attracts-US-22-4m-AU-34m-to-Fund-Phase-II-Development-of-INNA-051-Nasal-Spray-Designed-to-Protect-Against-Symptomatic-Viral-Respiratory-Infections.html

    GLOBENEWSWIRE
    22 Oct 2025
    Share Share
    ENA Respiratory Appoints Pharma Experts as Strategic Advisors
    ENA Respiratory Appoints Pharma Experts as Strategic Advisors

    06 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/06/3074736/0/en/ENA-Respiratory-Appoints-International-Pharma-Experts-as-Strategic-Advisors-to-Support-Development-of-INNA-051-Antiviral-Host-Defence-Enhancer.html

    GLOBENEWSWIRE
    06 May 2025
    Share Share
    ENA Respiratory with University of Maryland for Ph 2 Study
    ENA Respiratory with University of Maryland for Ph 2 Study

    09 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/09/3058150/0/en/ENA-Respiratory-Partners-with-University-of-Maryland-and-Leading-Respiratory-Disease-Expert-to-Conduct-Phase-2-Study-of-INNA-051-Antiviral-Host-Defence-Enhancer.html

    GLOBENEWSWIRE
    09 Apr 2025
    Share Share
    ENA Respiratory’s INNA-051 Promise Against Respiratory Infections
    ENA Respiratory’s INNA-051 Promise Against Respiratory Infections

    02 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/02/3053983/0/en/ENA-Respiratory-Announces-Publication-Supporting-the-Potential-of-its-Novel-Intranasal-Therapy-INNA-051-to-Reduce-the-Impact-of-Viral-Respiratory-Infections-in-Older-Adults.html

    GLOBENEWSWIRE
    02 Apr 2025
    Share Share
    ENA Respiratory Gets $5M From Flu Lab For INNA-051 Development
    ENA Respiratory Gets $5M From Flu Lab For INNA-051 Development

    10 Feb 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/02/10/3023216/0/en/ENA-Respiratory-Receives-US-5m-Investment-from-Flu-Lab-to-Support-Clinical-Development-of-Novel-Intranasal-Antiviral-Host-Defence-Immune-Enhancer-INNA-051.html

    GLOBENEWSWIRE
    10 Feb 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search